ORKA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Oruka Therapeutics, Inc.

NASDAQ | ORKA

27.36

USD

$0.00

(

0.00%

)

At Close (As of Oct 21, 2025)

$1.33B

Market Cap

-

P/E Ratio

-

EPS

$30.51

52 Week High

$5.49

52 Week Low

HEALTHCARE

Sector

ORKA Chart

Recent Chart
Price Action

ORKA Technicals

Tags:

ORKA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$27K
Total Revenue -
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$88M
Selling General And Administrative -
Research And Development $75M
Operating Expenses $88M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27K
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$82M
Net Income -$84M

Revenue & Profitability

Earnings Performance

ORKA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $396M
Total Current Assets $377M
Cash And Cash Equivalents At Carrying Value $62M
Cash And Short Term Investments $62M
Inventory -
Current Net Receivables -
Total Non Current Assets $19M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $18M
Short Term Investments $314M
Other Current Assets $1.2M
Other Non Current Assets -
Total Liabilities $14M
Total Current Liabilities $13M
Current Accounts Payable $3.5M
Deferred Revenue -
Current Debt -
Short Term Debt $213K
Total Non Current Liabilities $755K
Capital Lease Obligations $968K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $968K
Other Current Liabilities $9.4M
Other Non Current Liabilities -
Total Shareholder Equity $382M
Treasury Stock -
Retained Earnings -$84M
Common Stock $37K
Common Stock Shares Outstanding $17M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (None)
Operating Cashflow -$58M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $27K
Capital Expenditures $189K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$330M
Cashflow From Financing $450M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$84M

yearly Income Statement (As of Dec 31, 2024)

Field Value (None)
Gross Profit -$27K
Total Revenue -
Cost Of Revenue $27K
Costof Goods And Services Sold $27K
Operating Income -$88M
Selling General And Administrative -
Research And Development $75M
Operating Expenses $88M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense $1.5M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $27K
Income Before Tax -$84M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -
Comprehensive Income Net Of Tax -
Ebit -$82M
Ebitda -$82M
Net Income -$84M

Dividends

Field Value
Ex Dividend Date 2024-08-29
Declaration Date 2024-08-16
Record Date 2024-08-26
Payment Date 2024-08-28
Amount 1.613

ORKA Profile

Oruka Therapeutics, Inc. Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Oruka Therapeutics, Inc. is a forward-thinking biotechnology company dedicated to advancing innovative therapies that address critical medical needs across a range of chronic and complex diseases. By harnessing state-of-the-art research and development resources, the firm is positioned to bring transformative treatment solutions to market. With a robust pipeline of promising product candidates and a steadfast commitment to scientific rigor, Oruka Therapeutics is well-equipped to drive meaningful improvements in patient outcomes while generating substantial value for its investors.

BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
CLF
-17.24%
$13.39
AXDX
-61.36%
$0.03
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
GSIT
-16.26%
$10.86
RIG
+0.60%
$3.31
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
EOSE
+8.59%
$16.30
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
LAES
-5.86%
$6.10
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.86%
$66.62
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
IREN
-6.79%
$55.19
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
GPUS
-7.57%
$0.36
DCGO
+24.16%
$1.49
MARA
-3.18%
$20.07
HAL
+11.58%
$25.24
RMBL
+60.50%
$3.21
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
SNAP
+1.55%
$7.85
PBR
-1.11%
$11.56
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
VZ
-1.22%
$40.29
HBAN
+0.63%
$15.94
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
EPWK
-8.71%
$0.07
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
MSN
+59.31%
$0.76
AG
-11.21%
$12.75
BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
CLF
-17.24%
$13.39
AXDX
-61.36%
$0.03
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
GSIT
-16.26%
$10.86
RIG
+0.60%
$3.31
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
EOSE
+8.59%
$16.30
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
LAES
-5.86%
$6.10
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.86%
$66.62
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
IREN
-6.79%
$55.19
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
GPUS
-7.57%
$0.36
DCGO
+24.16%
$1.49
MARA
-3.18%
$20.07
HAL
+11.58%
$25.24
RMBL
+60.50%
$3.21
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
SNAP
+1.55%
$7.85
PBR
-1.11%
$11.56
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
VZ
-1.22%
$40.29
HBAN
+0.63%
$15.94
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
EPWK
-8.71%
$0.07
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
MSN
+59.31%
$0.76
AG
-11.21%
$12.75
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.